Non-Protein Kinase C C1-domain-containing protein

Non-Protein Kinase C (Non-PKC) C1-domain-containing proteins are a diverse group of signaling molecules that possess the conserved C1 domain, a cysteine-rich motif originally identified in Protein Kinase C (Source: NIH, PubMed). Unlike PKCs, these proteins exert their biological effects through distinct catalytic or scaffolding activities, including protein phosphorylation by Protein Kinase D (PKD), regulation of small GTPases by Chimaerins and RasGRPs, and vesicle priming by Munc13 (Source: ACS, Cell Signaling Technology). They serve as critical effectors for the second messenger diacylglycerol (DAG) and are the primary targets for phorbol esters and other C1-ligands (Source: NIH, BioRxiv). These proteins are involved in a wide array of cellular processes such as vesicle trafficking, cytoskeletal remodeling, and cell survival (Source: BioRxiv). Their dysregulation is implicated in various pathologies, including cancer, Alzheimer's disease, and HIV/AIDS, making them significant therapeutic targets (Source: NIH). Drugs like Bryostatin 1 and Ingenol mebutate interact with these proteins by binding to the C1 domain to modulate their activity (Source: NIH). However, the high structural conservation of the C1 domain across multiple protein families poses a significant challenge for the development of isoform-selective drugs (Source: NIH).

Other names

Non-PKC diacylglycerol effectorsNon-PKC phorbol ester receptorsC1-domain-containing non-PKC proteinsDAG-sensitive non-PKC proteinsNon-PKC C1-domain-containing proteins

These proteins are targeted via C1 domain agonism, antagonism, or allosteric modulation, where drugs mimic or compete with the endogenous second messenger diacylglycerol (DAG) to regulate protein translocation and activity (Source: NIH, BioRxiv).